I understand that in a number of countries, danazol has been restricted due to anti-doping regulations. However, in its use, particularly in the treatment of anemia in MPNs,, are there any restrictions in:
It is limited and not listed in the official essential drugs but danazol has also shown activity in treating anaemia in other haematological conditions including aplastic anaemia, myelodysplasia,myelo brosis,pureredcellaplasia, and other inherited bone marrow failure syndromes including Fanconi anaemia and dyskeratosis congenita.